Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Clinical trial NCT00381862 · COMPLETED

Trial details

NCT number: NCT00381862
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Nausea and Vomiting

Start date: 2006-06-01
Primary completion: 2008-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.